MYRIAD GENETICS, INC. Other Nonoperating Expense
MYRIAD GENETICS, INC. (MYGN) reported Other Nonoperating Expense of $439.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2013-11-12
- MYRIAD GENETICS, INC. other nonoperating expense for the quarter ending 2013-09-30 was $439.00K, a 242.97% increase year-over-year.
- MYRIAD GENETICS, INC. other nonoperating expense for the quarter ending 2013-06-30 was -$1.00K, a 100.48% decline year-over-year.
- MYRIAD GENETICS, INC. other nonoperating expense for the quarter ending 2013-03-31 was $111.00K.
- MYRIAD GENETICS, INC. other nonoperating expense for the quarter ending 2012-12-31 was -$14.00K, a 121.88% decline year-over-year.
- MYRIAD GENETICS, INC. other nonoperating expense for fiscal 2013 was $223.00K, a 45.21% decline from fiscal 2012.
- MYRIAD GENETICS, INC. other nonoperating expense for fiscal 2012 was $407.00K, a 15.30% increase from fiscal 2011.
- MYRIAD GENETICS, INC. other nonoperating expense for fiscal 2011 was $353.00K.
- MYRIAD GENETICS, INC. other nonoperating expense for fiscal 2010 was -$99.00K, a 103.97% decline from fiscal 2009.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2013-09-30 | $439.00K 10-Q · filed 2013-11-12 | $438.00K derived: sum of 2 quarters · filed 2013-11-12 | $549.00K derived: sum of 3 quarters · filed 2013-11-12 | $535.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $110.00K derived: sum of 2 quarters · filed 2013-08-14 | $96.00K derived: sum of 3 quarters · filed 2013-08-14 | $223.00K 10-K · filed 2013-08-14 |
| 2013-03-31 | $111.00K 10-Q · filed 2013-05-08 | $97.00K derived: sum of 2 quarters · filed 2013-05-08 | $224.00K 10-Q · filed 2013-05-08 | $433.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-12-31 | -$14.00K 10-Q · filed 2013-02-06 | $114.00K 10-Q · filed 2013-02-06 | $322.00K derived: sum of 3 quarters · filed 2013-11-12 | $316.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-09-30 | $128.00K 10-Q · filed 2013-11-12 | $336.00K derived: sum of 2 quarters · filed 2013-11-12 | $330.00K derived: sum of 3 quarters · filed 2013-11-12 | $394.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $202.00K derived: sum of 2 quarters · filed 2013-08-14 | $266.00K derived: sum of 3 quarters · filed 2013-08-14 | $407.00K 10-K · filed 2013-08-14 |
| 2012-03-31 | -$6.00K 10-Q · filed 2013-05-08 | $58.00K derived: sum of 2 quarters · filed 2013-05-08 | $199.00K 10-Q · filed 2013-05-08 | $278.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-12-31 | $64.00K 10-Q · filed 2013-02-06 | $205.00K 10-Q · filed 2013-02-06 | $284.00K derived: sum of 3 quarters · filed 2013-08-14 | $343.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-09-30 | $140.00K 10-Q · filed 2012-11-09 | $220.00K derived: sum of 2 quarters · filed 2013-08-14 | $279.00K derived: sum of 3 quarters · filed 2013-08-14 | $359.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-06-30 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $139.00K derived: sum of 2 quarters · filed 2013-08-14 | $219.00K derived: sum of 3 quarters · filed 2013-08-14 | $353.00K 10-K · filed 2013-08-14 |
| 2011-03-31 | $59.00K 10-Q · filed 2012-05-02 | $139.00K derived: sum of 2 quarters · filed 2012-05-02 | $273.00K 10-Q · filed 2012-05-02 | $268.00K derived: sum of 4 quarters · filed 2012-08-15 |
| 2010-12-31 | $80.00K 10-Q · filed 2012-02-01 | $214.00K 10-Q · filed 2012-02-01 | $209.00K derived: sum of 3 quarters · filed 2012-08-15 | $186.00K derived: sum of 4 quarters · filed 2012-08-15 |
| 2010-09-30 | $134.00K 10-Q · filed 2011-11-02 | $129.00K derived: sum of 2 quarters · filed 2012-08-15 | $106.00K derived: sum of 3 quarters · filed 2012-08-15 | -$180.00K derived: sum of 4 quarters · filed 2012-08-15 |
| 2010-06-30 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | -$28.00K derived: sum of 2 quarters · filed 2012-08-15 | -$314.00K derived: sum of 3 quarters · filed 2012-08-15 | -$99.00K 10-K · filed 2012-08-15 |
| 2010-03-31 | -$23.00K 10-Q · filed 2011-05-04 | -$309.00K derived: sum of 2 quarters · filed 2011-05-04 | -$94.00K 10-Q · filed 2011-05-04 | |
| 2009-12-31 | -$286.00K 10-Q · filed 2011-02-01 | -$72.00K 10-Q · filed 2011-02-01 | ||
| 2009-09-30 | $215.00K 10-Q · filed 2010-11-03 | |||
| 2009-06-30 | $2.49M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |